CVE-2020-2021
Published: March 25, 2022
Official Description
Palo Alto Networks PAN-OS contains a vulnerability in SAML which allows an attacker to bypass authentication.
CISA KEV Advisory
Palo Alto Networks PAN-OS Authentication Bypass Vulnerability
Palo Alto Networks PAN-OS contains a vulnerability in SAML which allows an attacker to bypass authentication.
Apply updates per vendor instructions.
Risk Analysis
This vulnerability in Palo Alto Networks PAN-OS allows an attacker to bypass authentication, potentially gaining unauthorized access to systems. The high EPSS score of 0.21125 indicates a significant likelihood of exploitation, making this a critical concern. Its inclusion in CISA's KEV further confirms active exploitation.
This vulnerability has been actively exploited in the wild, and its presence in CISA's KEV confirms its use by threat actors. The remote nature of the authentication bypass suggests it is remotely exploitable.
Organizations should apply the latest security updates and patches for Palo Alto Networks PAN-OS to address this authentication bypass vulnerability. Implement robust authentication mechanisms and monitor for suspicious access attempts.
Technical Analysis
CVE-2020-2021 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CISA has added CVE-2020-2021 to the Known Exploited Vulnerabilities (KEV) catalog, confirming active exploitation in the wild. U.S. federal agencies are required to patch this within the mandated timeframe, and all organizations should treat remediation as urgent.
Affected Vendors & Products
Exploit & PoC Resources
All References (1)
Quick Facts
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2020-2021 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
- !CISA KEV: Federal agencies must patch per BOD 22-01 timeline
- !Active exploitation confirmed — treat as P1